These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35386230)

  • 1. The Higher Expression of CDCA2 Associated with Poor Prognosis in Glioma.
    Jin X; Sun ZQ; Zhou GL; Li GJ; Deng SF
    Dis Markers; 2022; 2022():2184867. PubMed ID: 35386230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pan-cancer analysis reveals the diagnostic and prognostic role of CDCA2 in low-grade glioma.
    Li W; Lv D; Yao J; Chen B; Liu H; Li W; Xu C; Li Z
    PLoS One; 2023; 18(9):e0291024. PubMed ID: 37733705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CDCA2 promotes lung adenocarcinoma cell proliferation and predicts poor survival in lung adenocarcinoma patients.
    Shi R; Zhang C; Wu Y; Wang X; Sun Q; Sun J; Xia W; Dong G; Wang A; Jiang F; Xu L
    Oncotarget; 2017 Mar; 8(12):19768-19779. PubMed ID: 28423619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Impact of Cell Division Cycle Associated 2 Expression on Pancreatic Ductal Adenocarcinoma.
    Wang MY; Niu ZY; Gao XG; Zhou L; Liao Q; Zhao YP
    Chin Med Sci J; 2016 Sep; 31(3):149-154. PubMed ID: 27733221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CDCA2 protects against oxidative stress by promoting BRCA1-NRF2 signaling in hepatocellular carcinoma.
    Wang S; Cao K; Liao Y; Zhang W; Zheng J; Li X; Huang M; Zhong Y; Hu X; Chen D; Wang Y
    Oncogene; 2021 Jun; 40(25):4368-4383. PubMed ID: 34103686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CDCA2 promotes the proliferation of colorectal cancer cells by activating the AKT/CCND1 pathway in vitro and in vivo.
    Feng Y; Qian W; Zhang Y; Peng W; Li J; Gu Q; Ji D; Zhang Z; Wang Q; Zhang D; Sun Y
    BMC Cancer; 2019 Jun; 19(1):576. PubMed ID: 31196027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased CDCA2 Level Was Related to Poor Prognosis in Hepatocellular Carcinoma and Associated With Up-Regulation of Immune Checkpoints.
    Tang M; Liao M; Ai X; He G
    Front Med (Lausanne); 2021; 8():773724. PubMed ID: 35372372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integration analysis of cell division cycle-associated family genes revealed potential mechanisms of gliomagenesis and constructed an artificial intelligence-driven prognostic signature.
    Yu K; Tian Q; Feng S; Zhang Y; Cheng Z; Li M; Zhu H; He J; Li M; Xiong X
    Cell Signal; 2024 Jul; 119():111168. PubMed ID: 38599441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CDCA2 promotes proliferation and migration of melanoma by upregulating CCAD1.
    Jin WH; Zhou AT; Chen JJ; Cen Y
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6858-6863. PubMed ID: 32633378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of CDCA2 in human squamous cell carcinoma: correlation with prevention of G1 phase arrest and apoptosis.
    Uchida F; Uzawa K; Kasamatsu A; Takatori H; Sakamoto Y; Ogawara K; Shiiba M; Bukawa H; Tanzawa H
    PLoS One; 2013; 8(2):e56381. PubMed ID: 23418564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of GINS4 is associated with poor prognosis and survival in glioma patients.
    Liu B; Liu Z; Wang Y; Lian X; Han Z; Cheng X; Zhu Y; Liu R; Zhao Y; Gao Y
    Mol Med; 2021 Sep; 27(1):117. PubMed ID: 34556022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma.
    Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z
    BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CBX7 is a glioma prognostic marker and induces G1/S arrest via the silencing of CCNE1.
    Yu T; Wu Y; Hu Q; Zhang J; Nie E; Wu W; Wang X; Wang Y; Liu N
    Oncotarget; 2017 Apr; 8(16):26637-26647. PubMed ID: 28460453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated bioinformatics analysis and experimental validation identified CDCA families as prognostic biomarkers and sensitive indicators for rapamycin treatment of glioma.
    Li R; Chen Y; Yang B; Li Z; Wang S; He J; Zhou Z; Li X; Li J; Sun Y; Guo X; Wang X; Wu Y; Zhang W; Guo G
    PLoS One; 2024; 19(1):e0295346. PubMed ID: 38181024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CDCA2 Promotes HCC Cells Development via AKT-mTOR Pathway.
    Li K; Fan T; Shi Z; Jiang H
    Anal Cell Pathol (Amst); 2022; 2022():9912254. PubMed ID: 36588796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-targeting CDCA8 and E2F1 inhibits the growth and migration of malignant glioma.
    Wang X; Wang H; Xu J; Hou X; Zhan H; Zhen Y
    Cell Death Dis; 2021 Feb; 12(2):146. PubMed ID: 33542211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CDCA2 triggers in vivo and in vitro proliferation of hepatocellular carcinoma by activating the AKT/CCND1 signaling.
    Li J; Chen Y; Wang X; Wang C
    J BUON; 2021; 26(3):882-888. PubMed ID: 34268949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of CDCA2 as a Diagnostic and Prognostic Marker for Hepatocellular Carcinoma.
    Yu Z; Zhang Y; Shao S; Liu Q; Li Y; Du X; Zhang K; Zhang M; Yuan H; Yuan Q; Liu T; Gao Y; Wang Y; Hong W; Han T
    Front Oncol; 2021; 11():755814. PubMed ID: 34660326
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Qu S; Liu J; Wang H
    Front Immunol; 2021; 12():648416. PubMed ID: 33889156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CKS2 (CDC28 protein kinase regulatory subunit 2) is a prognostic biomarker in lower grade glioma: a study based on bioinformatic analysis and immunohistochemistry.
    Hu M; Li Z; Qiu J; Zhang R; Feng J; Hu G; Ren J
    Bioengineered; 2021 Dec; 12(1):5996-6009. PubMed ID: 34494924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.